MP36-02 A COMPARISION OF THE AORTIC-LESION-ATTENUATION-DIFFERENCE (ALAD) AND PEAK EARLY-PHASE ENHANCEMENT RATIO (PEER) TO PREOPERATIVELY DIFFERENTIATE BENIGN FROM MALIGNANT RENAL MASSES